Acute Disseminated Encephalomyelitis Associated With Chronic Cannabis Abuse

Tugce Akcan1, Milan Gajera1, Javad Najjar Mojarrab1

  • 1Internal Medicine, Marshfield Clinic Health System, Marshfield, USA.

Cureus
|March 29, 2022
PubMed

Insights

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory brain disorder. This case report details a young woman who developed ADEM following chronic cannabis abuse, a rare but significant association.

Area of Science:

  • Neuroimmunology
  • Neurology
  • Toxicology

Background:

  • Acute disseminated encephalomyelitis (ADEM) is an immune-mediated inflammatory demyelinating disorder of the central nervous system.
  • ADEM typically presents with acute neurological deficits and multifocal white matter lesions on MRI.
  • The etiology of ADEM is often post-infectious or post-vaccination, but other triggers are increasingly recognized.

Observation:

  • A young woman presented with acute neurological deficits.
  • Magnetic resonance imaging (MRI) revealed multifocal white matter abnormalities consistent with ADEM.
  • The patient had a history of chronic cannabis abuse.

Findings:

  • The patient was diagnosed with acute disseminated encephalomyelitis (ADEM).
  • The neurological condition was attributed to chronic cannabis abuse.
  • This represents the second reported case linking ADEM to cannabis use.

Implications:

  • Chronic cannabis abuse may be an underrecognized trigger for ADEM.
  • Further research is needed to elucidate the potential pathophysiological mechanisms linking cannabis and ADEM.
  • Clinicians should consider substance abuse, including cannabis, in the differential diagnosis of ADEM, especially in young individuals.